Kyobo 8 Special Purpose Acquisition Company - Asset Resilience Ratio
Kyobo 8 Special Purpose Acquisition Company (307280) has an Asset Resilience Ratio of 13.14% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Kyobo 8 Special Purpose Acquisition Comp for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Kyobo 8 Special Purpose Acquisition Company's Asset Resilience Ratio has changed over time. See free cash flow generation of Kyobo 8 Special Purpose Acquisition Comp to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Kyobo 8 Special Purpose Acquisition Company's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Kyobo 8 Special Purpose Acquisition Comp's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩7.08 Billion | 13.14% |
| Total Liquid Assets | ₩7.08 Billion | 13.14% |
Asset Resilience Insights
- Moderate Liquidity: Kyobo 8 Special Purpose Acquisition Company has 13.14% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Kyobo 8 Special Purpose Acquisition Company Industry Peers by Asset Resilience Ratio
Compare Kyobo 8 Special Purpose Acquisition Company's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 7.81% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Kyobo 8 Special Purpose Acquisition Company.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.91% | ₩7.10 Billion ≈ $4.81 Million |
₩47.63 Billion ≈ $32.28 Million |
+6.00pp |
| 2024-12-31 | 8.90% | ₩3.67 Billion ≈ $2.49 Million |
₩41.27 Billion ≈ $27.97 Million |
-3.96pp |
| 2023-12-31 | 12.87% | ₩5.52 Billion ≈ $3.74 Million |
₩42.90 Billion ≈ $29.08 Million |
-0.87pp |
| 2022-12-31 | 13.73% | ₩5.35 Billion ≈ $3.62 Million |
₩38.93 Billion ≈ $26.38 Million |
-- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more